Eli Lilly and Company

Historical 13F Holders

Symbol
LLY
CUSIP
532457108
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 4,037 821 M $676 B
2024 Q4 4,037 780 M $602 B
2024 Q3 3,813 798 M $694 B
2024 Q2 3,730 813 M $736 B
2024 Q1 3,623 826 M $641 B
2023 Q4 3,411 821 M $478 B
2023 Q3 3,106 787 M $423 B
2023 Q2 2,937 785 M $367 B
2023 Q1 2,725 842 M $270 B
2022 Q4 2,780 827 M $304 B
2022 Q3 2,603 799 M $259 B
2022 Q2 2,549 788 M $256 B
2022 Q1 2,434 791 M $226 B
2021 Q4 2,402 792 M $219 B
2021 Q3 2,154 792 M $183 B
2021 Q2 2,118 794 M $182 B
2021 Q1 2,032 793 M $148 B
2020 Q4 1,978 795 M $135 B
2020 Q3 1,861 736 M $109 B
2020 Q2 1,859 743 M $122 B
2020 Q1 1,776 753 M $104 B
2019 Q4 1,768 759 M $99.7 B
2019 Q3 1,613 746 M $83.5 B
2019 Q2 1,610 758 M $84.0 B
2019 Q1 1,709 783 M $101 B
2018 Q4 1,658 841 M $97.2 B
2018 Q3 1,531 848 M $90.9 B
2018 Q2 1,455 847 M $72.2 B
2018 Q1 1,417 845 M $65.4 B
2017 Q4 1,464 861 M $72.6 B
2017 Q3 1,306 851 M $72.7 B
2017 Q2 1,325 843 M $69.4 B
2017 Q1 1,347 847 M $71.2 B
2016 Q4 1,318 836 M $61.5 B
2016 Q3 1,262 836 M $67.1 B
2016 Q2 1,251 838 M $66.0 B
2016 Q1 1,217 849 M $59.9 B
2015 Q4 1,294 857 M $72.2 B
2015 Q3 1,202 852 M $71.5 B
2015 Q2 1,202 846 M $70.7 B
2015 Q1 1,162 843 M $61.3 B
2014 Q4 1,196 851 M $59.0 B
2014 Q3 1,109 839 M $54.6 B
2014 Q2 1,097 859 M $54.6 B
2014 Q1 1,096 836 M $49.6 B